CF

Infectious Disease·MeSH: Pseudomonas Infections

19 drugs in development·13 companies·0 clinical trials

Drug Pipeline by Phase

Approved(4)

Drug	Company
BRINSUPRI	INSMED Inc (INSM)
cayston	GILEAD SCIENCES, INC. (GILD)
kalydeco	VERTEX PHARMACEUTICALS INC / MA (VRTX)
trikafta	VERTEX PHARMACEUTICALS INC / MA (VRTX)

Phase 2(7)

Drug	Company
adrulipase	GridAI Technologies Corp. (GRDX)
Itepekimab	REGENERON PHARMACEUTICALS, INC. (REGN)
pur1900	Pulmatrix, Inc. (PULM)
sion-2851	Sionna Therapeutics, Inc. (SION)
sion-3067	Sionna Therapeutics, Inc. (SION)
sion-719	Sionna Therapeutics, Inc. (SION)
ttp273	vTv Therapeutics Inc. (VTVT)

Phase 1(4)

Drug	Company
CB-280	Calithera Biosciences, Inc. (CALA)
sion-109	Sionna Therapeutics, Inc. (SION)
sion-2222	Sionna Therapeutics, Inc. (SION)
sion-451	Sionna Therapeutics, Inc. (SION)

Unknown(2)

Drug	Company
IgG protein offering	Twist Bioscience Corp (TWST)
poly i	AIM ImmunoTech Inc. (AIM)

Phase 1/Phase 2(1)

Drug	Company
KB407	Krystal Biotech, Inc. (KRYS)

Phase 4(1)

Drug	Company
elexacaftor / ivacaftor / tezacaftor	GH Research PLC (GHRS)

Compare drugs

BRINSUPRI vs cayston BRINSUPRI vs kalydeco BRINSUPRI vs trikafta

Deep-dive into CF

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis

CF — Drugs in Development & Clinical Trials | BioSniper